Open AccessAssociation of Medication Regimen Complexity With Clinical Endpoints in Pediatric Patients With Cystic Fibrosis
Author(s) -
Shelby L. Tjugum,
Bjarne Hansen,
Cameron J. McKinzie
Publication year - 2021
Publication title -
the journal of pediatric pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 15
eISSN - 2331-348X
pISSN - 1551-6776
DOI - 10.5863/1551-6776-26.3.248
Subject(s) - medicine , cystic fibrosis , regimen , percentile , pediatrics , population , polypharmacy , retrospective cohort study , pharmacist , clinical endpoint , physical therapy , clinical trial , statistics , mathematics , environmental health , family medicine , pharmacy
Cystic fibrosis (CF) patients and caregivers are impacted by the number of pharmacological agents and unique administration needs; however, no data currently assesses how medication regimen complexity impacts clinical outcomes in this population. The objective of this study is to evaluate if an association exists between increased medication regimen complexity and clinical endpoints in pediatric patients with CF.